NASOPEN - 58809-729-04 - (Phenylephrine Hydrochloride, Thonzylamine Hydrochloride)

Alphabetical Index


Drug Information of NASOPEN

Product NDC: 58809-729
Proprietary Name: NASOPEN
Non Proprietary Name: Phenylephrine Hydrochloride, Thonzylamine Hydrochloride
Active Ingredient(s): 10; 50    mg/15mL; mg/15mL & nbsp;   Phenylephrine Hydrochloride, Thonzylamine Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of NASOPEN

Product NDC: 58809-729
Labeler Name: GM Pharmaceuticals, Inc
Product Type: HUMAN OTC DRUG
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20121003

Package Information of NASOPEN

Package NDC: 58809-729-04
Package Description: 118 mL in 1 BOTTLE (58809-729-04)

NDC Information of NASOPEN

NDC Code 58809-729-04
Proprietary Name NASOPEN
Package Description 118 mL in 1 BOTTLE (58809-729-04)
Product NDC 58809-729
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Phenylephrine Hydrochloride, Thonzylamine Hydrochloride
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20121003
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name GM Pharmaceuticals, Inc
Substance Name PHENYLEPHRINE HYDROCHLORIDE; THONZYLAMINE HYDROCHLORIDE
Strength Number 10; 50
Strength Unit mg/15mL; mg/15mL
Pharmaceutical Classes

Complete Information of NASOPEN


General Information